A detailed pathologic analysis was performed on Smn j/j ;SMN2 +/+ mice as a mouse model for human type I spinal muscular atrophy (SMA). We provide new data concerning changes in the spinal cord, neuromuscular junctions and muscle cells, and in the organs of the immune system. The expression of 10 synaptic proteins was analyzed in 3-dimensionally reconstructed neuromuscular junctions by confocal microscopy. In addition to defects in postsynaptic occupancy, there was a marked reduction in calcitonin geneYrelated peptide and Rab3A in the presynaptic motor terminals of some, but not all, of the skeletal muscles analyzed. Defects in the organization of presynaptic nerve terminals were also detected by electron microscopy. Moreover, degenerative changes in muscle cells, defective postnatal muscle growth, and prominent muscle satellite cell apoptosis were also observed. All of these changes occurred in the absence of massive loss of spinal cord motoneurons. On the other hand, astroglia, but not microglia, increased in the ventral horn of newborn SMA mice. In skeletal muscles, the density of interstitial macrophages was significantly reduced, and monocyte chemotactic protein-1 was downregulated. These findings raise questions regarding the primary contribution of a muscle cell defect to the SMA phenotype.
INTRODUCTION
Spinal muscular atrophy (SMA) is a motoneuron (MN) disease caused by deletions or inactivating mutations of the Survival Motor Neuron 1 (SMN1) gene, which results in reduced dosage of full-length SMN protein (1) . Spinal muscular atrophy is the second most common fatal autosomal recessive childhood disorder with an incidence of approximately 1 per 6,000 births (2, 3) . The deletion of SMN1 homologs in other animals is lethal at early embryonic ages (4) . Because the human genome contains a variable number of copies of a second paralogous gene, SMN2, the absence of SMN1 is partially compensated by SMN2. This is because the SMN2 gene mostly generates transcripts lacking exon 7 and produces a truncated and rapidly degraded nonfunctional SMN$7 protein. However, approximately 10% to 20% of SMN2 transcripts are correctly spliced and produce fulllength SMN. Because there is polymorphism with respect to the number of copies of SMN2, the levels of full-length SMN in SMA patients may vary and inversely correlate with the severity of the disease (5, 6) . Spinal muscular atrophy is a ubiquitously expressed protein that plays a prominent role in the assembly of small nuclear ribonucleoproteins in the nuclear Cajal body and in pre-mRNA splicing (7) . How reduced levels of SMN cause a MN disease in humans is not currently understood. Two alternatives have been proposed: 1) the SMA phenotype is a consequence of cellspecific defective small nuclear ribonucleoprotein biogenesis and pre-mRNA splicing; or 2) the disease is due to the loss of the MN-specific function of the SMN protein (3, 8) . SMN seems to be crucial for the transport of mRNA in neurons; therefore, disruption of this function may be pivotal in the pathogenesis of SMA (9) .
On the basis of conventional postmortem neuropathologic studies of the end-stages of disease, it has been historically assumed that the loss of ventral horn MNs and subsequent skeletal muscle atrophy are the most characteristic features of human SMA (10) . To gain further insight into the pathogenesis of SMA, mouse models of this disease have been generated (11Y16). Detailed studies charting the progression of the disease in SMA mice have concluded that defects in axons and their synaptic terminals at the neuromuscular junctions (NMJs) are associated with the most prominent and earliest changes (17Y21). Compromised NMJs have also been described in drosophila and zebrafish Smn mutants (22, 23) . This concept may be relevant to other MN diseases such as amyotrophic lateral sclerosis (ALS). Indeed, in ALS, it has been reported that synaptic disconnection at NMJs is a key aspect of the pathology and occurs earlier than 
MN death (24Y27). If clinical manifestations of MN diseases
result from damage in the distal motor axon but not from activation of the death pathway, new therapeutic strategies should be directed to protecting distal axons and synaptic motor terminals. Thus, a more precise knowledge of the nature of NMJ pathology may contribute to the definition of new targets for therapy.
Here, we report a detailed pathologic analysis of the Smn j/j ;SMN2 mouse model of type I SMA and provide new data concerning changes detected in the spinal cord, skeletal muscle (including NMJs), and immune system organs. We analyzed the expression of 10 synaptic proteins using multiple fluorescent labeling and confocal microscopy in NMJs and identified (in addition to defects in postsynaptic occupancy) marked and early downregulation of calcitonin geneYrelated peptide (CGRP) and Rab3A in the presynaptic motor terminals of some, but not all, of the SMA muscles analyzed. Defective postnatal muscle growth, degenerative changes in skeletal muscle cells, and prominent muscle satellite cell apoptosis were also detected. All of these changes occur in the absence of the massive loss of spinal cord MNs. These findings suggest a primary contribution of muscle defects to the SMA phenotype. Preliminary results of this work were presented in an abstract form (28) . was used for genomic DNA extraction and polymerase chain reaction setup. The primers used were as follows: WT forward 5 ¶ CTCCGGGATATTGGGATTG 3 ¶, SMA reverse 5 ¶ GGTAACGCCAGGGTTTTCC 3 ¶ and WT reverse 5 ¶ TTTCTTCTGGCTGTGCCTTT 3 ¶. Electrophoresis in 1% agarose gel and SYBR safe DNA stain (Molecular Probes, Eugene, OR) was run at 100 mV. In some experiments, newborn (P0Y1) Smn +/+ ;SMN2 +/+ mice were subjected to sciatic nerve axotomy: the right sciatic nerve was transected and ligated at the midthigh level under anesthesia by hypothermia. All experimental procedures used had been approved by the Committee for Animal Care and Use of the University of Lleida, in line with Generalitat de Catalunya norms (DOGC 2073 (DOGC , 1995 .
MATERIALS AND METHODS

Animals
Histology
Samples were fixed in Carnoy solution (60% ethanol, 30% chloroform, and 10% glacial acetic acid) to count healthy MNs. Serial paraffin sections (8 Km for E18; 12 Km for P0Y1 and P5Y6) obtained through the entire lumbar segment of spinal cord were stained with Cresyl violet, and every 10th section was counted according to established procedures (29) .
Immunocytochemistry and TUNEL Staining
The SMA and WT animals analyzed were pooled in 3 different groups: E18, P0Y1, and P5Y6. Spinal cords and the diaphragm (Diaph), intercostalis (IC), sternomastoid (StM), and lingual (Ling) muscles were separately dissected and fixed by immersion in 4% paraformaldehyde (PFA) in 0.1 mol/L phosphate buffer (PB) at pH 7.4 for 1 to 24 hours. Skinremoved whole limbs were equally fixed, and tibialis anterior (TA), gastrocnemius (GN), soleus (SOL), and extensor digitorum longus (EDL) muscles were then separately dissected. Samples were cryoprotected with 30% sucrose in PB, embedded in Tissue Freezing Medium (TFM Triangle Biomedical Sciences, Durham, NC), frozen, and stored at j80-C for cryostat sectioning. For spinal cords, transverse serial cryostat sections (16 Km thick) from thoracic and lumbar segments were obtained.
For immunocytochemistry (ICC), sections were sequentially rinsed in phosphate-buffered saline (PBS) containing 0.1% Triton X-100, blocked in 10% normal goat serum, and incubated with the primary antibody overnight at 4-C. The primary polyclonal rabbit antibodies used were anti-CGRP (Sigma; 1:1000), anti-Synaptophysin (SyPhys; Dako, Glostrup, Denmark; 1:100), antiYvesicular acetylcholine transporter (VAChT; Synaptic Systems, Göttingen, Germany; 1:1000), anti-Rab3A (Synaptic Systems; 1:200), antiYsynaptobrevin-1 (VAMP-1; Synaptic Systems; 1:1000), antiYsynaptotagmin 1 (SyTg; Synaptic Systems; 1:100), antiY cysteine string protein (CSP; Chemicon; 1:1000), anti-bassoon (Synaptic Systems; 1:200), antiYionized calcium-binding adaptor molecule 1 (Iba-1; Wako Pure Chemical Industries, Osaka, Japan; 1:500), antiYneurofilament 160 kDa (NF) (Chemicon, Temecula, CA; 1:500), and antiYcalcium channel (> 1B subunit) (Ca v 2.2; Sigma; 1:100). Other antibodies used included chicken polyclonal anti-NF 68 kDa (Abcam, Cambridge, UK; 1:1000), chicken polyclonal antiYglial fibrillary acidic protein (GFAP; Abcam; 1:1000), mouse monoclonal antiYsynaptic vesicle protein 2 (SV2; Hybridoma Bank, Iowa City, IA; 1:1000), mouse monoclonal anti-Pax7 (Hybridoma Bank; 1:100), and rat monoclonal antiYlaminin-2 (Sigma; 20 Kg/mL). In some cases, the chicken polyclonal anti-NF 68 was used instead of the rabbit antiYNF 160 to perform multiple immunolabeling with other rabbit antibodies. The anti-NF antibodies gave similar results and will be referred to as ''NF.'' Washed sections were incubated at room temperature (RT) for 1 hour with appropriate Cy3-and Cy5-labeled secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, PA) and with either AlexaFluor 488Y or AlexaFluor 647Ylabeled >-Bungarotoxin (Molecular Probes; 1:500) to identify postsynaptic acetylcholine receptors. Sections were also labeled with 4 ¶, 6-diamidino-2-phenylindole dihydrochloride (50 ng/mL; Molecular Probes) for DNA. Spinal cord sections were also labeled with fluorescent Neuro Trace Nissl staining (Molecular Probes).
Neuromuscular junctions were scored in a blinded manner and assigned to 1 of 3 groups according to the intensity of their immunoreaction: positive, mild (a very low signal but still distinguishable from the background), and negative.
To assess macrophage numbers, the sections were processed for immunoperoxidase staining with Iba-1 antibody, according to standard ABC (Vector Laboratories, Burlingame, CA) procedure.
Apoptosis was evaluated in muscle sections using TUNEL staining (In Situ Cell Death Detection Kit; POD, Roche, Penzberg, Germany) or active caspase-3 immunolabeling (Cell Signaling Technology, Danvers, MA; 1:200).
For Pax7 ICC, unfixed legs frozen in liquid N 2 -cooled isopentane were used. Cryostat sections (7 Km) were then For CGRP studies in the spinal cord, cryostat sections serially obtained through the entire thoracic and lumbar segments and labeled by immunoperoxidase were used. Numbers of CGRP-positive MNs were counted in every 30th section of thoracic and lumbar segments. Alternative sections were stained with Cresyl violet for evaluation of MN numbers.
Imaging was performed with an Olympus BX51 epifluorescence microscope (Olympus, Hamburg, Germany) equipped with a DP30BW camera or with a FluoView 500 Olympus laser scanning confocal microscope. Digital images were analyzed with Visilog 6.3 software (Noesis, Orsay, France).
Whole Mount Preparations
Flat muscles such as the Diaph, levator auris longus, and transversus abdominis (TVA) were dissected and briefly fixed in 4% PFA (1 hour), washed in PBS, and frozen at j20-C. The samples were treated with 20% normal horse serum containing 0.4% Triton X-100 (6Y8 hours) and incubated with primary antibodies on a shaking plate for 48 hours at 4-C. The primary antibodies used were anti-CGRP, anti-NF 160 kDa, anti-SyPhys, anti-Rab3A, and anti-SV2. Muscles were extensively washed with PBS containing 0.02%YTween 20 and incubated with the appropriate secondary antibody overnight at 4-C. Slides were washed with PBS, mounted in 30% glycerol, and 3-dimensionally (3D) imaged by confocal microscope. For 3D reconstructions, NMJs were optically sectioned into 0.5-Km thickness using a 60Â N/A 1.4 objective. In some cases, NMJs were 3D-reconstructed using Imaris Software (Bitplane, Zurich, Switzerland).
Muscle Fiber Morphometry
The SMA and WT mice legs were dissected, embedded in tragacanth gum, and snap-frozen in liquid N 2 -cooled isopentane. Cryostat sections (16 Km) were obtained and labeled with AlexaFluor 488Ylabeled wheat germ agglutinin (Molecular Probes; 25 Kg/mL) to delimitate individual muscle fibers for morphometry. Images were taken with the confocal microscope and analyzed with Visilog 6.3 (Noesis).
Electron Microscopy
Muscles were microdissected in Hanks solution, pinned onto Sylgard (Down Corning, Wiesbaden, Germany) plates, and fixed in a solution containing 1% glutaraldehyde and 1% PFA in 0.1 mol/L PB, pH 7.4, for 1 hour at 4-C. The samples were trimmed in PB, postfixed in 1% OsO 4 , and embedded in EMbed 812 (Electron Microscopy Sciences, Fort Washington, PA). Ultrathin sections were taken from selected areas containing NMJs (identified previously in toluidine blueYstained 1-Km-thick semithin sections), counterstained with uranyl acetate and lead citrate, and then examined in a Zeiss EM 910 (Zeiss, Oberkochen, Germany) electron microscope.
Western Blot
Animals were decapitated for subsequent dissection of their distal limb muscles, which were then rapidly frozen in N 2 , and stored at j80-C until use. Limb muscles were fragmented with ultra Turrax T8 homogenizer (IKA Labortechnik, Staufen, Germany) and homogenized with 200 KL of warmed blending buffer 1 Â SR (2% SDS and 125 mmol/L Tris-HCl, pH 6.8) and protease inhibitor (Sigma; ref. P8340) for 3 Â 10 seconds. The homogenized muscle was heated to 100-C for 5 minutes and centrifuged for 5 minutes at 12,000 rpm, and the supernatant was collected. The protein concentration was determined by BIO-RAD Micro DC protein assay (BIO-RAD, Madrid, Spain). The loading buffer 4 Â SS (20% sucrose and 0.05% bromophenol blue, 0.1% sodium azide) containing 5% to 10% A-mercaptoethanol (Sigma) and 20 to 30 Kg of protein was loaded in a 15% polyacrylamide electrophoresis gel. Proteins were electrotransferred to a PVDF (Immobilon-P; Millipore, Bedford, MA) membrane in Tris-glycine-methanol buffer. The membrane was blocked with 5% fat-free dried milk dissolved in 0.1% Tween 20 in Tris-buffered saline pH 8 (TBST), for 1 hour at RT, and then extensively washed in TBS. The membrane was incubated overnight with the primary rabbit antibody antiYmonocyte chemotactic protein-1 (MCP-1; Cell Signaling Technology; 1:1000) at 4-C with gentle agitation. The membrane was washed in TBST, incubated with a peroxidase-conjugated anti-rabbit IgG secondary antibody (1:5000; Amersham Biosciences, Buckinghamshire, UK) in TBST I for 30 minutes at RT, washed in TBST, and then visualized using a SuperSignal Chemiluminescent detection kit (Pierce, Rockford, IL), as described by the manufacturer.
Statistical Analysis
Data are expressed as mean T SEM. The statistical analysis was assessed by either one-way ANOVA (followed by post hoc Bonferroni test) or Student t-test. In all cases, differences were considered to be statistically significant if p G 0.05.
RESULTS
Phenotype, Survival, and Spinal Cord Changes in Severe SMA Mice
Nearly half of newborn Smn j/j ;SMN2 +/+ mice died on the first postnatal day (46.5% n = 39). Surviving animals showed a deficiency in weight gain and did not live beyond P7 (not shown). It seems that food intake deficiency, affecting the nutritional status of ill pups, is not a major contributor of SMA phenotype, that is, although all the animals had reduced body weights and muscular atrophy, only approximately 50% of end-terminal mice had an empty stomach at the time of sampling. Overall, these findings are consistent with previously published results relating to the same model (13, 30) .
In animals at advanced stages of the disease, moderate (approximately 20%) but significant loss of ventral horn MNs in the lumbar spinal cord was detected (Fig. 1A) . In newborn animals (P0Y1), some MN loss was observed, but because of individual variability, the change was not significant. No differences in MN numbers were observed at the lumbar spinal cord for embryonic ages (E18), indicating that naturally occurring MN programmed cell death, which takes place between E13 and E15 in the mouse spinal cord (31), was not altered as a consequence of SMN deficiency. To detect other possible changes to the spinal cord of SMA mice, immunostaining was performed for GFAP and Iba-1 to visualize astroglia and microglia, respectively. Whereas no changes were found in microglial cells (Fig. 1B) , astroglial processes around MNs increased in SMA. Quantification of the relative area of GFAPpositive structures within the ventral horn demonstrated that astroglia increased in SMA (3-fold in newborns and 5-fold at terminal stages of the disease). No changes were found in late embryonic (E18) stages (Figs. 1CYE) .
Defective Expression of Synaptic Proteins in Smn j/j ;SMN2 +/+ NMJs
Because severely paralyzed animals showed only a moderate MN loss in the terminal stage of the disease, we searched for changes in muscle and NMJs that could account for the motor deficit. Impairment of axonal transport proteins, including actin, and ribonucleoproteins throughout the motor nerves may be crucial in the pathogenesis of SMA (32, 33) . To detect early changes in NMJ proteins in severe SMA mice, we analyzed the expression of different presynaptic markers in the IC muscle using ICC. A battery of 9 different synaptic vesicle antibodies was used in combination with postsynaptic membrane labeling with >-Bungarotoxin (Fig. 2A) . The results shown in Figure 2A (in which mild and positive NMJ immunoreactivity results were pooled) indicate that most NMJs in terminally affected SMA animals were still innervated. Only È10% of synapses were devoid of the widely expressed synaptic vesicle proteins SyPhys or SV2; these 2 markers colocalized within the presynaptic compartment (Figs. 2BYE) . Presynaptic cytoskeletal NF followed a similar profile. The proteins involved in the acquisition of cholinergic phenotype and synaptic vesicle functionality (e.g. VAChT, VAMP-1 [involved in the exocytosis machinery], the calcium sensor SyTg, or Rab3A) were downregulated early (P0) in SMA. This was particularly prominent in the case of Rab3A because the number of Rab3A-depleted NMJs was È25% higher in P0Y1 SMA than in WT. A marked decline in Rab3A was also observed at P5Y6 SMA. Rab3A is involved in the activity-dependent transport of synaptic vesicles to, and their docking at, the active zone (34) . Calcitonin geneYrelated peptide was also markedly downregulated in P0Y1 SMA NMJs. This neuropeptide coexists with acetylcholine in separate vesicles in vertebrate NMJs (Figs. 2FYI) . It is stored in large dense core vesicles and shows remarkable developmental and plasticity regulation. For example, CGRP is transiently high in developing and regenerating NMJs (35Y39). In contrast to newborn WT IC, in which È22% of the NMJs were devoid of CGRP, this neuropeptide was absent in more than 60% of innervated SMA NMJs. It is interesting to note that sensory/visceral CGRP immunoreactivity was well preserved in SMA affected muscles (not shown), suggesting selective depletion of CGRP in the motor nerves and NMJs.
The expression of some synaptic proteins was also determined in embryonic (E18) SMA IC NMJs. No changes in early motor innervation were detected after Rab3A, NF 160 kDa, or SV2 or SyPhys immunolabeling. However, CGRP was significantly depleted in SMA NMJs (not shown). The development of postsynaptic apparatus was also found to be impaired in SMA, showing a reduction in the area of clustered acetylcholine receptors adjacent to the nerve terminal (È23% on E18 and 65% on P5Y6).
We next explored the expression of the representative NMJ proteins CGRP, SyPhys, and Rab3A to follow synaptic alterations in different SMA muscles (Table) . SOL, TA, GN, EDL, Ling, StM, and Diaph were all examined in cryostat sections. In contrast with the data obtained in the IC, CGRP downregulation was not found in TA, GN, Ling or EDL muscles in SMA. However, Diaph and, to a less extent, Ling both showed significantly decreased CGRP in SMA mice. Although not significant, data from StM also indicated that CGRP might be downregulated in this muscle. Changes in CGRP immunoreactivity could not be assessed in SOL because the peptide was absent in motor nerves of both WT and SMA mice in this muscle. Muscles showing CGRP downregulation usually displayed reduced Rab3A, as was seen in IC. However, denervated synapses, identified by their lack of SyPhys, were rarely found in all the muscles examined at the terminal stage of the disease.
Immunoreactivity of CGRP was also determined in ventral horn MNs (Figs. 3AYC) . As in the different muscle groups, CGRP was significantly depleted in thoracic but not in lumbar MNs in newborn SMA mice. Calcitonin geneY related peptide downregulation in thoracic MNs was not a consequence of the loss of any particular MN subtype because no significant loss of thoracic MNs was detected at this age (data not shown).
By ICC, Smn-deficient cultured MNs exhibited a reduced accumulation of the pore-forming subunit (Ca v 2.2) of the N-type voltage-gated Ca 2+ channels (VGCCs) in growth cones, which correlated with a reduced frequency of local Ca 2+ transients (40) . We applied the same antibody to tissue sections of SMA IC muscles. Although the immunoreaction showed some background and notable nonspecific nuclear staining, examination at high power under a confocal microscope revealed that the presynaptic clustering of Ca v 2.2 immunoreactivity was lost or reduced in samples from newborn SMA animals (Figs. 4AYI) .
The entire neuromuscular innervation was also studied in whole-mount preparations of flat muscles immunostained for NF, SyPhys, SV2, Rab3A, and CGRP. Although denervated NMJs were scarce, CGRP expression was markedly downregulated in the TVA of newborn SMA mice, but no clear evidence of Rab3A downregulation was seen until P5Y6 in this muscle (Table) . Neuromuscular junctions were imaged at high resolution with the confocal microscope, and a 3D reconstruction was made (Figs. 5AYH; Figure, Supplemental Digital Content 1, http://links.lww.com/NEN/A242). The complexity of the presynaptic apparatus and how and in which extent this fits with the postsynaptic membrane were evaluated in newborn TVA after SV2 plus NF immunostaining (Figs. 5IYN) . The results indicated that presynaptic organization was simplified in SMA; endplates had values of terminal axon arborization that were half those of the controls. In addition, occupation of the postsynaptic membrane area decreased more than 3-fold in SMA (Fig. 5O) . We detected other changes in SMA muscles that were in line with other published descriptions (17, 18) , including NF accumulation in the presynaptic terminals (Figs. 5P, Q) and axonal swellings in the intramuscular nerves (Fig. 5R) . Neuromuscular junctions containing NF aggregates in presynaptic terminals were quantified in whole mounts of TVA muscle at P5. In SMA mice, the percentage was 48.7% T 5.4%, whereas no NF aggregates were found in WT mice (number of NMJs analyzed = 97 from 4 WT mice and 235 from 6 SMA mice).
At P0Y1, many of the motor axon terminals in both levator auris longus and Diaph not only were restricted to postsynaptic territories but also overgrew and overshot the NMJs (not shown), but this was also observed in the Smn +/+ ;SMN2 +/+ that we used as a control. A similar observation was recently reported in this model (41, 42) .
Ultrastructural Changes in Muscles of SMA Mice
Intercostalis, TVA, Diaph, and TA muscles were analyzed by electron microscopy in newborn and terminal SMA mice and their WT littermates (Figs. 6AYJ) . From the qualitative point of view, comparable alterations were seen in all these muscles. These changes involved NMJs, muscle cells, and intramuscular nerves. At the NMJs, a large variety was observed in the size of presynaptic buttons, which is a normal feature of immature (P5Y6) remodeling synapses. However, in SMA mice, there were tiny presynaptic terminals. In addition, presynaptic nerve terminals were often detached from the postsynaptic membrane, and there were large areas of postsynaptic membrane unoccupied by synaptic terminals (Figs. 6A, B) . In some cases, detached nerve endings appeared to be surrounded by terminal Schwann cell processes, suggesting the active participation of these cells in the removal of nerve terminals from the postsynaptic sites (Fig. 6H) . Synaptic vesicles were abundant in large synaptic terminals and their sizes were similar to those in WT (WT = 51.7 T 0.3 nm, SMA = 53.4 T 0.3 nm). However, the number of active zones and their associated vesicles was reduced in SMA, suggesting that a deficiency in neurotransmitter release could have arisen from this alteration (Figs. 6C, D, J) . The number of autophagosome/lysosome-like structures was also increased inside presynaptic terminals in SMA (Fig. 6E) . Presynaptic NF accumulation was also seen in a form similar to that previously described (17) .
Most of the intramuscular nerves contained normally appearing axons, but occasional focal accumulation of autophagosome-like structures, indicative of axonal degeneration, was seen (Fig. 6G) . Spinal muscular atrophy muscles showed focally localized areas of Z band disruption and myofibrillar disorganization. This was particularly evident in the TA and TVA of end-terminal mice (Fig. 6F) .
Intercostalis and TA SMA muscles frequently exhibited mononucleated apoptotic cells within the muscle basal lamina (Figs. 7AYB ¶) . We deduced that these corresponded to muscle satellite cells because this morphology fits in with the definition of these cells (43) . The apoptotic satellite cells often appeared to be engulfed by macrophage-like cells lying inside the muscle basal lamina. These macrophage-like cells sometimes contained several apoptotic bodies (not shown).
Apoptotic Cell Death Is Increased in SMA Muscles
Muscle apoptosis was further evaluated after performing either active caspase-3 immunostaining or TUNEL reaction on IC and TA muscle sections. Both techniques gave similar results. As shown in Figures 7EYH , the density of active caspase-3 cells within muscle in SMA was similar to that in WT at the time of birth, but muscle apoptosis in SMA was approximately 5 to 20 times greater than in the controls in both of the muscles examined at P5Y6. By light microscopy, the apoptotic cells were located adjacent to muscle fibers (Fig. 7G) . Electron microscopy demonstrated that muscle cell apoptosis was frequently observed in satellite cells (Figs. 7AYB ¶) . When TUNEL staining was combined with laminin ICC to delineate muscle fiber basal lamina, it was found that 46.3% (T5.5%, n = 3 TA muscle from different P5Y6 SMA mice) of TUNEL-positive nuclei and muscle fibers shared the same basal lamina (Figs. 7C, C ¶) , as expected for muscle satellite cells (44) . TUNEL staining was also combined with the satellite cell marker Pax7. In that case, TUNEL-positive nuclei did not show Pax7 immunoreactivity (Figs. 7D, D ¶) . Because the apoptotic process involves abrupt changes in chromatin structure and proteolytic activity, it is possible that a transcription factor such as Pax7, which localizes within the nucleus, could be destroyed concomitantly with apoptosis; alternatively, satellite cells might die when Pax7 is downregulated (45) . Active caspase-3 immunostaining on P0Y1, both in WT and SMA, revealed the presence of large and elongated apoptotic muscle fibers together with apoptotic mononucleated cells, indicating that the process of transient and normally occurring muscle cell death appears at this age (Fig. 7F) . A considerable number (53.7%) of muscle apoptosis in SMA corresponded to interstitial cells. Although exploration of the nature of these cells is out of the scope of the present study, we suggest that they may correspond to interstitial macrophages clearing apoptotic satellite cells or/and muscle resident (interstitial myogenic nonsatellite) stem cells (46) .
To explore whether muscle apoptosis is a process linked to Smn j/j ;SMN2 +/+ phenotype or, alternatively, a secondary response to denervation, sciatic nerve axotomy was performed on newborn (P0Y1) Smn +/+ ;SMN2 +/+ mice. Cleaved caspase-3 immunoreactivity was evaluated in denervated TA muscles 48 and 72 hours after axotomy. Contralateral (normally innervated) TA muscles were used as controls. No significant differences in the number of apoptotic profiles were found between ipsilateral (denervated) and contralateral TA muscles (48 hours after axotomy: ipsilateral = 5.1 T 1.7, contralateral = 8.3 T 4.4, n = 3; 72 hours after axotomy: ipsilateral = 23.8 T 12.6, contralateral = 24.8 T 12.7, n = 2; expressed in apoptosis/mm 2 ). By contrast, it should be noted that, in newborn rats, virtually all spinal cord MNs have already died by apoptosis 48 hours after sciatic nerve transection (47) .
Analysis of the postnatal growth of TA muscle after measuring individual muscle fiber size was concordant with a defect in postnatal myogenesis. The distribution frequency of muscle fiber size in newborn animals was similar for both the SMA and WT TA muscles (Figs. 8AYD) . However, it seems that muscle growth was further arrested, that is, the fiber size histograms on P5Y6 were similar to P0Y1 in SMA mice. This contrasted with WT mice, in which the P5Y6 histogram was shifted to the right because of normal muscle growth. The characteristic, large hypertrophic fibers usually present in human SMA muscles were not seen in severe SMA mice.
Depletion of Interstitial Macrophages in Muscles and Atrophy of Immune Organs in SMA Mice
Because apoptosis with subsequent macrophage recruitment was apparently stimulated in SMA muscles, we analyzed the status of interstitial macrophages in these muscles. Sections of TA, IC, Ling, and StM muscles were immunostained with antiYIba-1 antibody to detect the macrophage population; positive cell densities were also assessed (Figs. 9AYD) . Surprisingly, in P5Y6 SMA, all the muscles examined displayed a notable reduction of macrophage density. When these measurements were made in newborns, no differences were observed between WT and SMA (Fig. 9E) . Because MCP-1 is a factor involved in the recruitment of monocytes in connective tissues, the expression of this protein was analyzed in limb WT and SMA muscle extracts. As shown in Figures 9F and G, MCP-1 was significantly downregulated in P5Y6 SMA.
To determine whether macrophage depletion was tissuespecific, the density of Iba-1Ypositive cells was also measured in the spleen and liver, but no differences between SMA and WT were observed in these organs. However, the weights of the spleen and thymus were reduced by approximately 4-to 6-fold in P5Y6 SMA versus WT. Weights of other organs, such as the kidney and liver, were only reduced 2-fold in SMA, following the same profile observed for the whole body (Figs. 9HYJ) .
In most SMA mice, histologic studies showed that there was massive cortical lymphocyte apoptosis in the thymus at terminal disease stages (8/11 of the animals examined). Apoptosis was demonstrated by several techniques: hematoxylin and eosin staining of paraffin sections, 4 ¶, 6-diamidino-2-phenylindole dihydrochloride staining on cryostat sections, toluidine blueYstained plastic sections, and electron microscopy (Figs. 9KYN) . No relationship was found between thymus apoptosis and gastric milk depletion.
DISCUSSION
Our phenotypic analysis of Smn j/j ;SMN2 +/+ mice shows that instead of MN death, early NMJ defects are the pathologic hallmark of SMA. For example, the number of lumbar MNs was not significantly reduced in newborn SMA mice, and only a moderate loss (È20%) was observed at the end stage of the disease. However, some early alteration may occur at the spinal cord because detectable ventral horn astrocytosis was found before MN death. Astroglial activation is frequently associated with MN pathology in ALS and after axotomy; it may have complex and opposite, that is, either neuroprotective or neurotoxic, effects (48, 49) . How reactive astrocytes affect MN function and synaptic connectivity in SMA should be investigated further. It is interesting to note that the number of glutamatergic terminals on MN cell bodies is reduced in SMA mice (50, 51) . The absence of noticeable spinal cord microgliosis suggests that, in contrast to the SMA $7 model, neuroinflammation is not a relevant mechanism in the most severe SMA mice (50) . Nevertheless, several alterations in NMJs, which correlate with the disease progression, were seen. Some of these data are in line with other reports on the SMA mice model in which NF accumulation and the simplification of presynaptic terminals are described as early detectable pathologic features (17Y21). In addition, we provide evidence that some molecular components of presynaptic terminals were downregulated in normally innervated NMJs of the most severely affected proximal muscles (i.e. IC, TVA, and StM). In these muscles, there was a remarkable fall in Rab3A and CGRP, whereas other synaptic vesicle markers such as SyPhys and SV2 were normal or slightly decreased. Rab3A is a GTP-binding protein involved in targeting synaptic vesicles to the active zones and in neurotransmitter release in nerve terminals (52, 53) . In Rab3A null mutants, the activity-dependent recruitment of synaptic vesicles to active zones and the recovery of synaptic transmission after exhaustive stimulation were both impaired (34) . Therefore, it is conceivable that Rab3A depletion in SMA results in comparable defects in transmitter release in neuromuscular synapses. In fact, the evoked neurotransmitter release has been found decreased in severe SMA mice before the appearance of extensive denervation (21, 54) . Our data on active zone reduction in SMA presynaptic terminals are consistent with the observed molecular and functional alterations and in accordance with data published in the SMA $7 model (21). The organization of presynaptic active zones is tightly linked to VGCCs, which play an important role as scaffolding proteins through their interaction with laminin A 2 (55) . Therefore, the downregulation of VGCCs we found in SMA is in concordance with the reduction in active zones.
We observed early depletion of CGRP in presynaptic terminals in apparently normal synapses. As CGRP was not equally expressed in different muscles and ages (56) , its implication in SMA can only be assessed when compared with appropriate matched controls. For example, CGRP was found to be downregulated in proximal SMA-affected muscles such as IC and TVA, whereas it was normally expressed in less affected distal muscles. However, in slow-twitch SOL muscle, CGRP was absent in both SMA and controls. Calcitonin geneYrelated peptide is normally present in the CNS and, particularly, in cell bodies of large subpopulations of cranial and spinal MNs (57Y60). This peptide is regulated during the development, plasticity, and regeneration of nerves and NMJs (36Y39, 61, 62) . It has been reported that CGRP enhances the postsynaptic response at developing NMJs through CGRP-receptor binding and cAMP-dependent signaling (63) . It has also been proposed that CGRP is a nerve-derived activator of the transcription of postsynaptic acetylcholine receptors (64) . Whether CGRP reduction in SMA contributes to depressed neuromuscular transmission should be elucidated. It seems that the depletion of CGRPcontaining vesicles in SMA NMJs may not be a consequence of reduced axonal transport because MN cell bodies in the thoracic spinal cord, which innervate proximal muscles, also showed reduced CGRP levels. The possibility that a deficiency in mRNA axonal transport accounts for CGRP depletion in SMA should also be investigated because an intra-axonal synthesis of CGRP occurs during peripheral nerve regeneration (62) . The specificity of CGRP downregulation in the SMA motor system should be noted because the expression of this peptide in the sensory and autonomic nervous system remained unchanged. The fact that CGRP was not decreased in SMA lingual NMJs suggests that they are not severely affected in this model; conversely, a slight but significant increase in CGRP was observed. It should be noted that, although this neuropeptide is downregulated during postnatal development in most of adult muscles, it remains highly expressed in adult tongue NMJs (37, 38, 56) . Because CGRP is also upregulated in regenerating nerves and synapses (39) , it is possible that the increase in CGRP particularly observed in SMA tongue reflects plastic (reparative) events.
Increased muscle satellite cell apoptosis in muscles of P5Y6 SMA animals correlated with disease progression. Apoptosis in other muscle cell types was virtually absent after extensive ultrastructural screening. Therefore, the mononucleated active caspase-3Y and TUNEL-positive cells observed by light microscopy were likely mainly satellite cells. Whether satellite cell apoptosis is a consequence of SMN deficiency or a secondary response to muscle denervation, or both, cannot be yet stated. It is believed that satellite cells are the source of myogenic precursors for postnatal muscle growth (65) and that this is largely due to the formation of secondary myotubes (66) . During the embryonic development of rats, primary myotubes develop autonomously even in the absence of innervation, but the generation of secondary myotubes is regulated by nerves (67) . Our histograms showing the arrest of muscle fiber growth in SMA suggest that the generation of secondary myotubes was impaired and that satellite cell apoptosis might account for this. On the other hand, deletion of Smn exon 7 directed to muscle satellite cells is sufficient to induce severe myopathy, indicating that muscle in itself is an important contributor to SMA pathology (68) . Likewise, SMN gene mutation restricted to skeletal muscle results in a process of myopathic degeneration (14) , and intact satellite cells improve myopathy induced by SMN deficiency (68) . Our data showing apoptosis in SMA satellite cells are parallel observations of a large number of apoptotic nuclei in muscle biopsies from children with SMA (69, 70) .
In contrast to P5Y6 mice, we observed that both WT and SMA newborn (P0Y1) muscles had apoptosis. This probably reflects processes of normal developmental muscle remodeling. Although, as far as we know, there are no available systematic studies on developmentally regulated programmed cell death in mammalian muscle, there is evidence that muscle cell death occurs during normal development in the chick embryo (71) .
With regard to the presumed specific role of SMN protein in muscle cells, it has been reported that SMN participates in the structural organization of the Z band (72) . Our frequent observation that areas with focal myofibrillar disorganization in the Z band were preferentially disrupted whereas adjacent myosin and actin filaments remained unaffected in SMA muscle is consistent with this.
On the basis of the finding of stimulated apoptosis within SMA muscle, we expected that the recruitment of macrophages destined to eliminate dying cells would lead to an increased density of interstitial macrophages in the muscle connective tissue. However, we observed just the opposite: SMA muscles exhibited between 25% and 50% lower macrophage density versus controls. It is known that macrophages in skeletal muscle are highly versatile cells with opposing functions, that is, they either increase tissue damage or promote tissue growth and repair (73) . In addition, macrophages exert an antiapoptotic action on muscle satellite cells, as has been shown in vitro; it has also been also demonstrated that MCP-1 is one of the major factors influencing monocyte chemotaxis by muscle precursor cells (74) . Although we found that MCP-1 was decreased in SMA muscle extracts, whether macrophage depletion is related to increased muscle precursor apoptosis and a deficiency in postnatal myogenesis should be investigated further. In any case, macrophage depletion was tissue-specific because it was not observed in either the liver or the spleen.
There was massive apoptosis in the thymus cortex of SMA mice. A similar phenotype of massive death of the cortical lymphocytes was reported in TrkB-deficient mice and a role for TrkB signaling in the regulation of thymus apoptosis was suggested (75) . Similarly, SMN may be involved in the mechanisms that determine cortical thymus lymphocyte apoptosis, but we do not have evidence to support this hypothesis. Alternatively, enhancement of thymocyte apoptosis could be a secondary response in terminally stressed animals. In fact, glucocorticoids and restraint stress can induce apoptotic thymus involution (76, 77) . However, the fact that we observed a selective atrophy of immune organs such as the thymus and spleen suggests a possible primary defect in the immune system in severe SMA mice. It has recently been demonstrated that SMN depletion in cell types other than MNs may significantly contribute to SMA pathology (50) . In addition, systemic immune aberrations and spleen atrophy have been reported in a mouse ALS model (78) .
In summary, our results sustain the idea that the maintenance of NMJ innervation is severely affected in SMA and that defective skeletal muscle development may be a crucial pathogenetic element in this disease. In addition, the conspicuous pathologic alteration detected in the immune system organs of SMA animals deserves further attention.
